Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage.
Streptococcus dysgalactiae subsp. equisimilis (SDSE) isolates are the most common group C streptococci in humans and reports of invasive infections associated with SDSE have been increasing. Molecular epidemiology studies are an important strategy to trace the emergence and spread of possible well-fit bacterial pathogens of humans and animals. In this work, we analysed the antimicrobial and clonal profiles of 115 SDSE infection and colonization isolates of human and equine origin. PFGE revealed the spread of two main clusters: clone A (57.4%) and clone A (26.1%). Remarkably, two isolates from clone B obtained from human colonization cases displayed identical PFGE patterns to those of three equine infection isolates. In addition, multilocus sequence typing allocated these isolates to ST129 (CC31). All of the SDSE isolates were susceptible to penicillin, vancomycin, gentamicin, levofloxacin and chloramphenicol. Tetracycline and erythromycin resistance rates were 65.2 and 13.9% respectively. Nevertheless, none of the isolates displaying sporadic PFGE patterns showed erythromycin resistance. The majority of erythromycin-resistant isolates from clone A had inducible resistance to macrolides, lincosamines and streptogramins B (iMLSB phenotype), which is associated with the presence of the ermA gene, whereas the resistant isolates from clone B showed the M phenotype, associated with the mefA gene. In conclusion, the data indicated that the analysed collection of SDSE isolates displayed a clonal structure and that the isolates found in human colonization cases could also be involved in equine infections.
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, RJ, Brazil.
Ligia Guedes
LG
Silva
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, RJ, Brazil.
Gabrielle Limeira
GL
Genteluci
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, RJ, Brazil.
Marcos
M
Corrêa de Mattos
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, RJ, Brazil.
Thaís
T
Glatthardt
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, RJ, Brazil.
Agnes Marie
AM
Sá Figueiredo
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, RJ, Brazil.
Bernadete Teixeira
BT
Ferreira-Carvalho
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001938:Brazil / Q000453:epidemiology; D016000:Cluster Analysis; D024881:Drug Resistance, Bacterial; D016521:Electrophoresis, Gel, Pulsed-Field; D014644:Genetic Variation; D005838:Genotype; D006736:Horses; D006801:Humans; D008826:Microbial Sensitivity Tests; D017720:Molecular Epidemiology; D058885:Multilocus Sequence Typing; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000662:veterinary*; D013291:Streptococcus / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents